Mori Y - Search Results

1

Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation.

Mori Y, Tamai H, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Ichinose M. Mori Y, et al. Hepatol Res. 2015 Jan;45(1):75-87. doi: 10.1111/hepr.12311. Epub 2014 Apr 2. Hepatol Res. 2015. PMID: 24533527

2

Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma.

Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Mori Y, et al. Hepatol Int. 2009 Sep;3(3):509-15. doi: 10.1007/s12072-009-9131-4. Epub 2009 Apr 29. Hepatol Int. 2009. PMID: 19669252 Free PMC article.

3

Assessment of malignant potential of small hypervascular hepatocellular carcinoma using B-mode ultrasonography.

Moribata K, Tamai H, Shingaki N, Mori Y, Enomoto S, Shiraki T, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Moribata K, et al. Among authors: mori y. Hepatol Res. 2011 Mar;41(3):233-9. doi: 10.1111/j.1872-034X.2010.00763.x. Epub 2011 Jan 27. Hepatol Res. 2011. PMID: 21272166

4

Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.

Enomoto S, Tamai H, Shingaki N, Mori Y, Moribata K, Shiraki T, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Enomoto S, et al. Among authors: mori y. Hepatol Int. 2011 Jun;5(2):730-7. doi: 10.1007/s12072-010-9245-8. Epub 2011 Jan 9. Hepatol Int. 2011. PMID: 21484138 Free PMC article.

5

Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.

Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Shirai K, et al. Among authors: mori y. Hepatol Res. 2011 Aug;41(8):738-45. doi: 10.1111/j.1872-034X.2011.00841.x. Epub 2011 Jun 23. Hepatol Res. 2011. PMID: 21699637

6

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.

Tamai H, Shingaki N, Shiraki T, Tukuda H, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Yanaoka K, Oka M, Ichinose M. Tamai H, et al. Among authors: mori y. Hepatol Res. 2011 Dec;41(12):1137-44. doi: 10.1111/j.1872-034X.2011.00879.x. Epub 2011 Sep 26. Hepatol Res. 2011. PMID: 21951330

7

Low-dose pegylated interferon-alpha-2a monotherapy in elderly and/or cirrhotic patients infected with hepatitis C virus genotype-2 or genotype-1 low level infection.

Tamai H, Moribata K, Mori Y, Shingaki N, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Tamai H, et al. Among authors: mori y. Hepatol Res. 2013 Jul;43(7):702-8. doi: 10.1111/hepr.12024. Epub 2012 Dec 17. Hepatol Res. 2013. PMID: 23252609

8

Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M. Moribata K, et al. Among authors: mori y. World J Hepatol. 2012 Dec 27;4(12):374-81. doi: 10.4254/wjg.v4.i12.374. World J Hepatol. 2012. PMID: 23355915 Free PMC article.

9

Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks.

Wada Y, Tamai H, Uno A, Kawashima A, Shingaki N, Mori Y, Moribata K, Miyata K, Higashi K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Wada Y, et al. Among authors: mori y. Hepatol Res. 2014 Feb;44(2):179-86. doi: 10.1111/hepr.12101. Epub 2013 Mar 27. Hepatol Res. 2014. PMID: 23531032

10

Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.

Ueno M, Hayami S, Shigekawa Y, Kawai M, Hirono S, Okada K, Tamai H, Shingaki N, Mori Y, Ichinose M, Yamaue H. Ueno M, et al. Among authors: mori y. J Hepatol. 2015 Dec;63(6):1352-9. doi: 10.1016/j.jhep.2015.07.013. Epub 2015 Jul 23. J Hepatol. 2015. PMID: 26212030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,874 results

Search Page

Filters